Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282815 · ClinicalTrials.gov registry record · Phase 2
Sleep Apnea Treatment After Stroke (SATS)
A Phase 2 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00282815 is a Phase 2 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 32 participants.
The verdict
NCT00282815, a Phase 2 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if treating stroke patients who have obstructive sleep apnea with continuous positive airway pressure will improve symptoms caused by the stroke.
Interventions
- DEVICE sham CPAP
- DEVICE continuous positive airway pressure or CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282815
The ClinicalTrials.gov registry entry for NCT00282815 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sham CPAP is the first listed.
NCT00282815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282815 about?
NCT00282815 is a clinical study titled "Sleep Apnea Treatment After Stroke (SATS)". The purpose of this study is to determine if treating stroke patients who have obstructive sleep apnea with continuous positive airway pressure will improve symptoms caused by the stroke.
What is the current status of trial NCT00282815?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-09. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00282815?
The interventions under investigation include: sham CPAP (DEVICE), continuous positive airway pressure or CPAP (DEVICE).
Who is sponsoring clinical trial NCT00282815?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.